Perfluamine

CAS No. 338-83-0

Perfluamine( Perfluorotripropylamine | FTPA | Tris(perfluoropropyl)amine )

Catalog No. M27102 CAS No. 338-83-0

Perfluamine is a hydrophobic carrier fluid and can be used as a blood substitute.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 27 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Perfluamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Perfluamine is a hydrophobic carrier fluid and can be used as a blood substitute.
  • Description
    Perfluamine is a hydrophobic carrier fluid and can be used as a blood substitute.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Perfluorotripropylamine | FTPA | Tris(perfluoropropyl)amine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    A2B
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    338-83-0
  • Formula Weight
    521.072
  • Molecular Formula
    C9F21N
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rüsing D, et al. The impact of adenosine and A(2B) receptors on glucose homoeostasis. J Pharm Pharmacol. 2006 Dec;58(12):1639-45.
molnova catalog
related products
  • Arg-Gly-Asp-Cys

    Arg-Gly-Asp-Cys is the binding motif of fibronectin and cell adhesion molecules, which can inhibit platelet aggregation and fibrinogen binding.

  • Xanthohumol

    Xanthohumol has anti-hepatitis C virus, anti-carcinogenic, free radical-scavenging, and anti-inflammatory activities, it can inhibit HIV-1 induced cytopathic effects, the production of viral p24 antigen and reverse transcriptase in C8166 lymphocytes at non-cytotoxic concentration.

  • Nogo-66 (1-40)

    Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.